Colgate University Biotechnology Symposium 2005


Windows	Welcome & Opening Remarks Rebecca Chopp, President of Colgate University
Windows	Keynote address - “Frontiers of Neurotherapeutics” Dr. Gerald D. Fischbach ‘60 Executive Vice President for Health and Biomedical Sciences and Dean of the Faculty of Medicine, Columbia University
Windows	“The Business of Biotechnology” G. Kirk Raab ’59, Chairman, Connetics Corporation
Windows	"Whither Big Pharma: Niche Opportunities for Drug Discovery." Jonah Shacknai ’78, Founder and CEO, Medicis Pharmaceutical Corporation
Windows	“Modern Drug Discovery: Convergence of Biology, Chemistry and Physics” Dr. Harvey J. Berger ’72, Founder, Chairman and CEO, ARIAD Pharmaceuticals, Inc.
Windows	"Molecular genetic approaches to obesity and diabetes" Dr. Rudolph L. Leibel ’63, Professor of Pediatrics and Medicine, Columbia University
Windows	“The Future of Health Care in a Networked World” Dr. Jay H. Sanders ’59, President and CEO, The Global Telemedicine Group
Windows	Q&A: Question on trends in obesity
Windows	Q&A: Question on pricing and public perception of the pharmaceuticals industry
Windows	Q&A: Question on advances in brain pharmacology
Windows	Q&A: Question on the cost of bringing a new drug to market
Windows	Q&A: Question on pharmaceutical regulation in the U.S. and Canada
Windows	Closing Remarks by Dr. Fischbach